A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine maximum tolerated dose (MTD), dose limiting
toxicities (DLT) and recommend a proper dose for our phase II study of S-1 when combined with
radiation therapy for locally advanced or recurrent gastric cancer.